Respiratory syncytial virus infection has serious implications for children, older people and other vulnerable groups
A national respiratory syncytial virus (RSV) vaccination programme for newborns and older or vulnerable adults has begun, making the UK the world’s first nation to attempt such coverage.
Nursing Standard. 39, 10, 59-61. doi: 10.7748/ns.39.10.59.s20
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more